Our internationally recognised publications give you access to the expertise of hundreds of the world’s leading scientists, experts and researchers.

Our unrivalled collection of publications spans evidence-based clinical knowledge, research and regulatory information. The extensive breadth of content on MedicinesComplete supports your decision making, from research to the point of care and provides you with the world’s most trusted resources.

We’re excited to announce the launch of two new resources: Martindale’s ADR Checker, a quick and easy tool to support you when managing patients with adverse drug reactions, and the Palliative Care Formulary, the expert source of drug information in palliative and hospice care.

Subscribe Publication Updates

Publication Updates

11 Jan
Stockley's Herbal Medicines Interactions logo
Stockley’s Herbal Medicines January 2022

Pharmacopoeial information has been updated.

Minor Updates: British Pharmacopoeia, European Pharmacopoeia and USP-NF information has been globally updated.

11 Jan
British National Formulary for Children logo
BNF for Children January 2022 Update

This update contains 6 significant changes, 1 dose change and 1 deleted preparation.

Significant Changes:
• Adrenaline/epinephrine auto-injectors: reminder for prescribers to support safe and effective use [MHRA/CHM advice].
• COVID-19: updated guidance.
• COVID-19 vaccines: updated guidance in-line with Public Health England/UK Health Security Agency recommendations.
• Malaria, prophylaxis: updated guidance in-line with Public Health England recommendations.
• Phenobarbital: updated information on the available oral solutions and advice from the RCPCH/NPPG can be found in the prescribing and dispensing section of the Phenobarbital monograph.
• Yellow fever vaccine, live (Stamaril®): new pre-vaccination checklist [MHRA/CHM advice].

Dose Changes:
• Adrenaline/epinephrine [update to dosing for acute anaphylaxis].

Deleted Preparations: Tacni® [tacrolimus].

For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes

11 Jan
Stockley's Interactions Checker_logo
Stockley’s Interactions Checker January 2022 Update

New and updated interactions now available

For January, 300 new interactions have been added, and 83 existing interactions have been updated.

11 Jan
Handbook on Injectable Drugs logo
ASHP Injectable Drug Information January 2022 Update

This update contains 4 new monographs, 133 revised monographs and 1 discontinued monograph.

New monographs: Remimazolam Besylate; Ephedrine hydrochloride; Decitabine; Sotrovimab

Revised monographs: Topotecan Hydrochloride; Tramadol Hydrochloride; Linezolid; Rocuronium Bromide; Alprostadil; Argatroban; Azithromycin; Dexmedetomidine Hydrochloride; Methylprednisolone Acetate; Mycophenolate Mofetil Hydrochloride; Ertapenem Sodium; Palonosetron Hydrochloride; Pantoprazole Sodium; Anidulafungin; Caspofungin Acetate; Levothyroxine sodium; Micafungin Sodium; Tigecycline; Voriconazole; Doripenem; Esomeprazole Sodium; Moxifloxacin Hydrochloride; Ceftaroline Fosamil; Levetiracetam; Acetaminophen; Tranexamic Acid; Dalbavancin Hydrochloride; Posaconazole; Tedizolid Phosphate; Oritavancin Diphosphate; Ceftolozane Sulfate-Tazobactam Sodium; Peramivir; Ceftazidime-Avibactam Sodium; Sodium Thiosulfate; Bacitracin; Delafloxacin Meglumine; Meropenem-Vaborbactam; Omadacycline Tosylate; Aprepitant; Cefiderocol Sulfate Tosylate; Ibuprofen; Iron Sucrose; Bamlanivimab; Casirivimab-Imdevimab; Etesevimab; Albumin Human; Amikacin Sulfate; Aminophylline; Amphotericin B; Ascorbic Acid; Atropine Sulfate; Calcium Gluconate; Cefazolin Sodium; Clindamycin Phosphate; Colistimethate Sodium; Dexamethasone Sodium Phosphate; Diazepam; Digoxin; Diphenhydramine Hydrochloride; Dobutamine Hydrochloride; Dopamine Hydrochloride; Doxycycline Hyclate; Epinephrine Hydrochloride; Fentanyl Citrate; Furosemide; Gentamicin Sulfate; Haloperidol Lactate; Heparin Sodium; Hydrocortisone Sodium Succinate; Hydromorphone Hydrochloride; Insulin; Iron Dextran; Isoproterenol Hydrochloride; Ketamine Hydrochloride; Lidocaine Hydrochloride; Magnesium Sulfate; Mannitol; Methylprednisolone Sodium Succinate; Metoclopramide Hydrochloride; Metronidazole; Morphine Sulfate; Multivitamins; Naloxone Hydrochloride; Nitroglycerin; Norepinephrine Bitartrate; Pentobarbital Sodium; Phenobarbital Sodium; Phenylephrine Hydrochloride; Phenytoin Sodium; Polymyxin B Sulfate; Potassium Chloride; Potassium Phosphates; Sodium Chloride; Sodium Nitroprusside; Sodium Phosphates; Succinylcholine Chloride; Terbutaline Sulfate; Tobramycin Sulfate; Trimethoprim-Sulfamethoxazole; Vancomycin Hydrochloride; Lorazepam; Acyclovir Sodium; Bumetanide; Labetalol Hydrochloride; Aztreonam; Imipenem-Cilastatin Sodium; Ranitidine Hydrochloride; Vasopressin; Esmolol Hydrochloride; Midazolam Hydrochloride; Famotidine; Ganciclovir Sodium; Alteplase; Octreotide Acetate; Ondansetron Hydrochloride; Vecuronium Bromide; Ciprofloxacin; Fluconazole; Amiodarone Hydrochloride; Amoxicillin Sodium-Clavulanate Potassium; Milrinone Lactate; Diltiazem Hydrochloride; Filgrastim; Ketorolac Tromethamine; Piperacillin Sodium-Tazobactam Sodium; Tacrolimus; Propofol; Cefepime Hydrochloride; Levofloxacin; Meropenem; Nicardipine Hydrochloride; Cisatracurium Besylate; Remifentanil Hydrochloride; Users Guide

Discontinued monograph: Imdevimab

11 Jan
British National Formulary logo
British National Formulary January 2022 Update

This update contains 9 significant changes, 2 dose changes, 5 new monographs and 1 deleted preparation.

Significant Changes:
• Adrenaline/epinephrine auto-injectors: reminder for prescribers to support safe and effective use [MHRA/CHM advice].
• Arrhythmias: updated guidance for the management of atrial fibrillation.
• COVID-19: updated guidance.
• COVID-19 vaccines: updated guidance in-line with Public Health England/UK Health Security Agency recommendations.
• Dapagliflozin (Forxiga®) 5mg should no longer be used for the treatment of Type 1 Diabetes Mellitus [MHRA/CHM advice].
• Malaria, prophylaxis: updated guidance in-line with Public Health England recommendations.
• Mexiletine: update to include new indication for life-threatening ventricular arrhythmias.
• Phenobarbital: oral doses for children have been removed from the BNF; these can still be accessed in BNF for Children, where additional information on the available oral solutions and advice from the RCPCH/NPPG can be found in the prescribing and dispensing section of the Phenobarbital monograph.
• Yellow fever vaccine, live (Stamaril®): new pre-vaccination checklist [MHRA/CHM advice].

Dose Changes:
• Adrenaline/epinephrine [update to dosing for acute anaphylaxis].
• Calcium gluconate [update to dosing for acute severe hyperkalaemia].

New Monographs:
Lagevrio® [molnupiravir].
Lumykras® [sotorasib].
Ponvory® [ponesimod].
Tepmetko® [tepotinib].
Tukysa® [tucatinib].

Deleted Preparations: Tacni® [tacrolimus].

For further details on changes in the BNF click on https://www.medicinescomplete.com/#/content/bnf/PHP107699

11 Jan
Palliative Care Formulary January 2022 Update

This update contains 6 revised monographs.

The following monographs have been fully revised:
Diamorphine; Tapentadol.

The following monographs have undergone minor revision:
Drugs for oral inflammation and ulceration; Haemostatics; Oral candidosis; Parecoxib.

View more